Measuring Fluid Buildup in Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJens Rikardt Andersen
About this trial
The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include:
* Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized)
Participants will:
* Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.
Eligibility criteria
Qualifiers
Habile
Must be able to speak and read Danish
Has received/is receiving radiotherapy due to breast cancer within the last 6 months
Is being followed in the Oncology Outpatient Clinic at Aalborg University Hospital
Disqualifiers
Pregnant or breastfeeding women
Amputated limb(s)
Pacemaker or implanted cardioverter-defibrillator due to risk of interference from the electrical signal
Metallic prostheses due to risk of interference with the device signal
Trial design
Treatments tested in this trial
- Not listed
Trial groups
46 Participants
are grouped into 2 trial groupsSponsors and collaborators
Jens Rikardt Andersen
Lead sponsor
University of Copenhagen
Sponsor institution
Aalborg University Hospital
Collaborator
University of Copenhagen
Collaborator
Source ClinicalTrials.gov